North Growth Management’s Boston Scientific BSX Stock Holding History

North Growth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-170,000	Closed	-$7.37M	–	51
2021 Q3	$7.37M	Buy	170,000 +1,000	+0.6%	+$44.2K	1.3%	41
2021 Q2	$7.24M	Hold	169,000	–	–	1.18%	43
2021 Q1	$6.52M	Hold	169,000	–	–	1.16%	39
2020 Q4	$6.06M	Sell	169,000 -12,000	-7%	-$433K	1.24%	39
2020 Q3	$6.92M	Sell	181,000 -20,000	-10%	-$771K	1.52%	36
2020 Q2	$7.05M	Sell	201,000 -16,000	-7%	-$576K	1.69%	31
2020 Q1	$7.08M	Sell	217,000 -26,000	-11%	-$1.02M	1.99%	29
2019 Q4	$11M	Hold	243,000	–	–	2.46%	15
2019 Q3	$9.88M	Hold	243,000	–	–	2.38%	19
2019 Q2	$10.4M	Hold	243,000	–	–	2.58%	14
2019 Q1	$9.31M	Sell	243,000 -50,000	-17%	-$1.91M	2.49%	17
2018 Q4	$10.3M	Hold	293,000	–	–	2.89%	12
2018 Q3	$11.3M	Sell	293,000 -14,000	-5%	-$489K	2.85%	13
2018 Q2	$10M	Sell	307,000 -70,000	-19%	-$2.11M	2.53%	16
2018 Q1	$10.3M	Hold	377,000	–	–	2.65%	12
2017 Q4	$9.35M	Buy	+377,000	New	+$10.4M	2.45%	18

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

North Growth Management's BSX Position: Q4 2021 in Review

North Growth Management sold out of Boston Scientific (BSX) in Q4 2021, closing a stake of 170,000 shares — an estimated $7.37M sold.

North Growth Management first reported a position in BSX in Q4 2017 and held it in 16 quarters. The position peaked at $11.3M in Q3 2018. 888 funds tracked by Wall St. Rank hold BSX as of Q4 2021.

North Growth Management reported no remaining Boston Scientific position as of Q4 2021 after selling out during the quarter.
North Growth Management sold 170,000 Boston Scientific shares in Q4 2021, an estimated $7.37M.
North Growth Management first reported a position in Boston Scientific in Q4 2017 and held it in 16 quarters.
North Growth Management's Boston Scientific position peaked at $11.3M in Q3 2018.
888 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2021.

Based on North Growth Management's 13F filing for Q4 2021, filed 7 Feb 2022.